Medical Marijuana Inc (MJNA)

[Alan Brochstein]

KannaLife, run by a former penny stock promoter and a movie maker, is a joke. The CFO too has been associated with penny stock disasters. They have access to that patent for one specific use only: Hepatic encephalopathy. You can read more about what I am saying here.

When Ms. Sides talked about MJNA becoming a biotech play on April 30th, I thought that was so appropriate. Why? Because MJNA already acts like a biotech: NO cashflow, constant dilution.

To actually fund a drug for HE to Phase 3 trial completion would take years and tens of millions of dollars. KannaLife is just another gimmick in my view. Stick to CBD and make it happen.

I also think that MJNA's marketing of CanChew gum by referring to that patent is another joke. That patent has nothing to do with CanChew gum.